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Advanced-Stage Cervical Carcinomas Are Defined 
by a Recurrent Pattern of Chromosomal Aberrations 
Revealing High Genetic Instability and a Consistent 
Gain of Chromosome Arm 3q
Kerstin Heselmeyer,1-2 Merryn Macville,1 Evelin Schröck,1 Harald Biegen,2 Ann-Cathrin Hellström ,3 
Keerti Shah,4 G ert Auer,2 and Thomas Ried1*
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W e have analyzed 30 cases of advanced-stage cervical squamous cell carcinoma (stages lib—IV) by comparative genomic 
hybridization (CGH). The most consistent chromosomal gain in the aneupioid tumors was mapped to chromosome arm 3q in 
77% of the cases. Acquisition of genetic material also occurred frequently on Iq (47%), 5p (30%), 6p (27%), and 20 (23%). 
Recurrent losses were mapped on 2q (33%), 3p (50%), 4 (33%), 8p (23%), and 13q (27%). High-level copy number increases 
were mapped to  chromosome 8, chromosome arms 3q, 5p, 8q, I2p, I4q, I7q, I9q, 20p, and 20q, and chromosomal bands 
3q26-27, 9p23-24, I I q22-23, and 12p 13. In the majority of the cases, the presence of high-risk human papilloma virus genomes 
was detected. High proliferative activity was accompanied by crude aneuploidy. Increased p2l/W AF-l activity, but low or 
undetectable expression of TP53 were representative for the immunophenotype. This study confirms the Importance of a gain 
of chromosome arm 3q in cervical carcinogenesis and identifies additional, recurrent chromosomal aberrations that are 
required for progression from stage I tumors to advanced-stage carcinomas. Genes Chromosom. Cancer 19:233-240, 
1997. © 1997 Wiley-Liss, Inc j
mas. CGH serves as a molecular cytogenetic screen­
ing test that allows mapping of chromosomal copy 
number changes on normal metaphase chromo­
somes (Kallioniemi et al., 1992). Therefore, tumor 
cell culture is not required, and archival tissue 
sections that were formalin fixed and paraffin 
embedded can be used for analysis (Speicher et al., 
1993; Isola et aL, 1994). This feature of CGH is
particularly useful when a phenotype/genotype 
analysis in solid tumor progression is attempted 
(Ried et al., 1996). We have recently applied CGH 
to identify chromosomal aberrations that occur 
during the genesis of cervical carcinomas. T h e  
analysis of DNA extracted from normal cervical 
epithelium, mild, moderate, and severe dysplasias, 
and invasive carcinomas (stage I) has shown that 
the emergence of copy number increases of chromo­
some arm 3q defines the transition from preinva-
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INTRODUCTION
Cervical carcinomas are the second most com­
mon tumors in women worldwide. T h e  tumor 
incidence shows strong variability, with industrial­
ized countries having lower morbidity and mortality 
rates than do developing countries (Pisani et al., 
1993). T h is  variation is attributable mostly to cyto­
logic screening programs (Hakama et al., 1986). 
Although other factors, such as cigarette smoking, 
may influence the incidence of cervical cancer, 
infection with hum an papilloma virus (HPV) is the 
initiating event for cervical carcinogenesis (IARC, 
1995). It is conceivable, however, that additional,
4
genetic aberrations are required for the multistep 
process of tumor initiation and progression (Fearon 
and Vogelstein, 1990; zur Hausen, 1994). Determ i­
nation of mandatory genetic aberrations for tumor 
progression would potentially lead to diagnostic 
predictors. T h e  search for recurrent chromosomal 
aberrations in cervical carcinomas, however, was 
hampered by technical difficulties in karyotype 
analysis by means of chromosome banding tech­
niques (Atkin et al., 1990). We have therefore used 
comparative genomic hybridization (CGH) to iden­
tify recurrent gains and losses in cervical carcino-
© 1997 Wiley-Liss, Inc. T h is  an ide  is a US Government work and, as 
such, is in the public domain in the United States of America.
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sive to invasive tumors (Heselmeyer et al., 1996). In 
order to explore the relevance of the gain of 
chromosome arm 3q in advanced stages of tumor 
progression and to identify additional copy number 
changes, we have performed CGH on 30 cases of 
stage l ib  to IV squamous cell carcinomas of the 
uterine cervix.
MATERIALS AND METHODS
Tissue Samples
Thirty tumors were collected at the Karolinska 
Hospital, Stockholm, Sweden, between 1991 and 
1995. All tumors were diagnosed as cervical squa­
mous cell carcinomas. Patient age and tumor stag­
ing are presented in Table 1. T h e  tumors were 
staged based on clinical and histologic assessment 
according to the International Federation of Gynae­
cology and Obstetrics (FIGO) (Shepherd, 1989). 
Consecutive sections were cut from all formalin- 
fixed, paraffin-embedded samples. T h e  tissue sec­
tions were used for DNA ploidy measurements 
(thickness 8 pm), immunohistochemistry (4 pm), 
and tumor DNA extraction (50 pm). T h e  last 
section (4 pm) was stained with hematoxylin-eosin 
(H&E) for confirmation of the presence of tumor 
tissue. All tumor samples were obtained before 
treatment.
DNA Cytometry
DNA content measurements were performed by 
image cytometry on Fculgen-stained histologic sec­
tions as described (Auer et al., 1989; Auer et al.,
1994). All DNA values were expressed in relation to 
the corresponding staining controls, which were 
given the value 2c, indicating the normal diploid 
DNA content. T h ree  classes of histograms were 
obtained: 1) tetraploid cases with a main peak in the 
4c region and no cells or only a minor fraction of 
cells (less than 5%) exceeding 5c; 2) aneuploid/ 
proliferating tetraploid cases with a peak in the 4c 
region and a fraction of 5-20% of the cells exceed­
ing 5c; and 3) aneuploid cases with a main peak 
around the 4c region and more than 20% of the cells 
exceeding 5c. Examples of the histograms are 
shown in Figure 1.
Immunohistochemistry
Proliferative activity was determined with an 
antibody (MIB-1) directed against the Ki-67 anti­
gen. T h e  antibody distinguishes cells in GO from 
cells that are in G1-S-G2-M phase of the cell cycle. 
p21/YVAF-l expression w as. analyzed with the
WAF-1 antibody (Oncogene Sciences, Uniondale, 
NY), and TP53 expression was determined with 
the DO-1 antibody (Santa Cruz Biotechnology, 
Santa Cruz, CA). Immunohistochemistry was per­
formed essentially as described (Steinbeck et al.,
1995). T h e  quantification of the results is presented 
in Table 1.
H P V  Genotyping
HPV genomes in the  purified D N A  samples 
were identified by polymerase chain reaction (PCR), 
with the MY09-MY11 L I  consensus primers used 
for amplification (Bosch et al., 1995). We used 25 
type-specific probes and one generic HPV probe to 
diagnose the HPV type in the PC R  products 
(Hildesheim et al., 1994). p-globin amplification 
was used as a positive control for evaluation of the 
adequacy of tumor DNA,
C G H
C G H  was performed according to standard proce­
dures (Heselmeyer et al., 1996). Tumor DNA was
extracted from sodium isothiocyanate-treated, for­
malin-fixed tissue sections as described (Ried et 
a l ,  1995). Nick translation was performed with 
bio-16-dUTP (tumor DNA) and digoxigenin-11- 
clUTP (reference DNA, prepared from a karyotypi- 
cally normal female donor). Five hundred nano- 
grams of each of the labeled genomes was combined 
and hybridized with an excess of Cot-1 DNA 
(25 j-ig) to metaphase chromosomes prepared from a 
karyotypically normal donor. T h e  biotin-labeled 
tumor genome was visualized with avid in conju­
gated to fluorescein isothiocyanate (F IT C ) (Vector 
Laboratories, Burlingame, CA), and the digoxigenin- 
labeled reference D N A  with a mouse anti-digoxin 
antibody (Sigma, St. Louis, MO), followed by 
detection with a goat anti-mouse antibody conju­
gated to te tram ethy]rhodam ine  isothiocyanate 
(T R IT C ) (Sigma). Chromosomes were counter­
stained with DAPI to generate a G-like banding 
pattern.
Gray scale images of the DAPI counterstain, the
F IT C -labe led  tumor DNA, and the T R IT C -  
labeled reference D N A  from at least 8 metaphases 
from each hybridization were acquired with a cooled 
C C D  camera (CH250, Photometries, Tucson, AZ) 
connected to a Leica D M R B E  microscope equipped 
with fluorochrome-specific optical filters TR1, TR2, 
and T R 3  (Chroma Technology, Brattlcboro, VT). 
Quantitative evaluation of the hybridization was 
achieved with a custom-designed computer pro-
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TABLE I. Summary of the Clinical Data and Results From MIB-1, D O -1, WAF- 1 Staining, DNA Ploidy Measurements,
HPV Genotyping, and CGH in Advanced Cervical Carcinomas3
Patient
age
(years)
%
Case
List
no.
Tumor
stage
MlB-1
(Ki-67)
DO-I
(p53)
W AF-1 / 
P2I DNA HPV CGH
1 Cl 69 lllb 100 Neg. <2 6.6c, A 45 — 2q36-ter,~ 3p21 - 12,4- 3q26.1 -ter,4- 4- 5p,—5q35-ter, 
— 6q,-8pter-22,4-4-8q, -  ! lq , -  I3ql i—14,—X
2 C3 84 Hib 40 20 50 2.8c, A 16 4- I q,4-3(4- + 3q26—27),—5pter~ 14,+7, + + 8 ,—9pter-2( > 
— I4q31-ter,—X
3 C6 46 lib 90 Neg. 60 3.6c, A/pT 16 — 2q34-ter,4-3q25-ter,~ 6q25-ter,4-4-9pter-23, 
— 11 q22-ter,4-Xpter-q 13
4 C7 50 lllb 90 20 40 5.1c, A 39 4- Iq,4-2p,4-3q2l-ter,—4p IS-qter,4-5p,4-5q3 l-ter, 
+6p,+9q,+ I2p,-f I2q23-ter, 4- I3q3i-ter,
- 14q22-24,+ 15q24-25,4-16,+ 17p,++ 17q,
4-19q,4-20p,4- 4-20q,4-22
5 C8 36 lib 90 <2 10 8.0c, A/pT 45 4- I q,—2q3 6-ter, 4- 3q, —4pter-q23,—4q34~ter,4- 5p, 
-~5q 14—23,4-6p,+ 4-1 I q22—23, 4-16,—22,4-Xp
6 C9 87 (lib 80 10 40 5.8c, A 31 4- I2 q 3 6 - te r ,— I0q26-ter,4- 12,4- I4q24-ter, 
4-15,— 18q23-ter,4-Xq
7 C l) 72 lllb 90 10 30 4.1 c, A/pT 16 4- lq,4-3q,4-4- I2pl3
8 CI3 42 lllb 80 <2 30 6. Ic, A 45 —8pter-23
9 CIS 74 lllb 70 <2 30 4.3c, A/pT 16 4“ I q,—3p,4-3q,~ 8p,4-15
10 Cl 6 71 lllb 90 Neg. 10 3.8c, A 33 —3pter-q2l,4'3q22~terl4-5q,~8p,4-8q,— I Iql4-ter, 
— 14,— 16q,4-4-20p,~X
II C 18 67 lib 60 60 60 5.2c, A Neg. 4-6p,4-6q2l~22,4-4-19q,4-20p,4- 4-20q,4-Xpter-q 13
12 CI9 62 lib 50 20 50 3.8c, T Neg. 4-3q
13 C20 38 lib 90 Neg. Neg. 4.0c, A/pT 45 — 3p,~4,4-4-5p,—5ql l-23,4-6pter-2l,-9p,4~I2q, 
4-13q32-ter,— 14,— 17p,-H 17q, 4- I9ql 3.2-ter,-X
14 C2I 36 lllb 50 Neg. 70 4.0c, T 16 — 3p,-f-3q,—4,— 10,— I lpter-15,— I Iq22-ter
15 C22 74 lib 80 <2 60 4.0c, T 16 4-13p,4~3q,4- 4-5p,4-6p,—6q,4- 4-9pter-24,~ 13,4-X
16 C23 58 lib 50 20 50 3.6c, T 16 4-1 q,—2q36-ter, — 3p, 4-3q(-H -h3q24-cer),—6q, 
—7q2l-ter,4-9,- lOq
17 C24 46 IV 90 Neg. 60 4.2c, A/pT 16 — 2pter-24,~2q32~ter,-3p2l-l l,4-3q,-4,— 13,4-14
18 C26 75 lib 60 10 40 3.8c, A/pT Neg. 4-1 q,—6,— 14,—Xq21 -ter
19 C27 87 (Kb 60 Neg. 70 4.0c, A/pT Neg. 4-1,4-2p, —3p, + 3q,—5p,—9p,4-X
20 C29 72 IVa 20 80 60 4.1 c, A/pT Neg. 4-1q,-2q22-ter1“ 3p,4-3q24-ter,~4q,-8p,4-8q, 
-  17p,— I8q,~2l
21 C30 81 lllb 90 Neg. 40 3.8c, A/pT 31 4- lq,-2q36-ter,~3p2M  l,+3q23-ter,-4q,-6p, 
“ 6q26-ter,-9p,- I Op, -  I lpter-14,4-1 Ipl3-ql3, 
-  11 q 14-ter, —1 3 -1 7pter-1 2 ,-18,4-Xq22-24
22 C3I 63 IVa 80 Neg. 80 5.0c, A 52 4- 4“ 3q21 -ter,—4p,4~ 4-5pter-13,4-6, - 8p,4-8q,
4-9,+ 4- I2p,4- I2q,— !3q 14-22,4-18,4-20, 4-22
23 C32 79 lllb 90 10 20 n.d. 18
1
4- 1,4-3q,4-6,4-8,4-9,+ 10,4- 4- 14,4- (5,4- 16,4- 17q,— I8q, 
4- 19,4*2 0 ,+ 2 1
24 C33 64 lib 80 Neg. 50 4.1 c, A/pT 45 — 3p,4-3q(+ 4q2 l~22, ~ 6,— 13,4- 15q2 l-25
25 C34 51 lllb 80 5 30 7.0c, A/pT 16 4'5p,4-9q,— I2p,4-12q,—X
26 C36 54 lllb 90 5 70 6.7c, A/pT 16 4- Iq,4-3q2i-ter,4-6pter-l2,4~9p,4-17
27 C37 84 lib 80 Neg. 70 4.6c, A/pT 35 — 2q34- t e r , - 3p ,+ 3q1—6,—9p,— !4q2 l - 23,4- 15q22—-25, 
- l 7p,4-20
28 C39 34 lib 60 Neg. 70 4.0c, T 45 — 3p,—4p,4-5p,—5q33-ter,~ 13
29 C40 50 Ilia 90 5 30 5.2c, A 16 4-3q2 Uter,-f I9q
30 C42 81 lllb 90 <2 50 6.2c, A 16 —2q,—3p,4- 4-3q , - 4q,4- 4-5p,-l-5q , - 8pter-23, - 9p,
-  I0p , -  11,~  I2p,~ 13, 4- I4q22- te r ,+ 17,4- 19,4-20
’MiB-1, DO-1, and WAF- 1 immunohistochemicai results are presented as percentages of the tumor cells that reacted with the respective antibody, DN A 
ilstograms are classified as tetraploid (T), aneuploid/proliferating tetraploid (A/pT), and aneupioid (A) (see also Fig. l).n.d., not determined. The HPV 
:ypes are provided as determined by dot blot analysis. Neg., negative for detection of HPV sequences. The CGH column shows the chromosomal 
iberrations detected in individual cases.
*ram, the  details of which are described by du images (Fig. 2D,EX We used average ratio profiles 
vlanoir et al. (1995). Average ratio profiles were to identify chromosomal copy number changes in 
computed as the  m ean value of at least 8 ratio all cases.
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Figure !. Examples of tetraploid (A), aneuploid/proliferating tetra- 
ploid (B ), and aneuploid (C) DNA content histograms. See Materials 
and Methods for details of the classification.
RESULTS
We recently identified a gain of chromosome arm 
3q as a recurrent chromosomal aberration that 
occurs at the transition from preinvasive to invasive, 
early-stage cervical carcinomas (Heselmeyer et al., 
1996). We performed the present study to address 
the question whether gain of 3q is maintained when 
the tumors progress, and to identify additional 
chromosomal aberrations that might be required for 
further progression of cervical carcinomas. We now 
report the mapping of chromosomal gains and 
losses in 30 cases of advanced-stage cervical carcino­
mas. T he  clinical data are summarized in Table 1.
CGH Analysis
Genomic tumor DNA was extracted from 50 pm 
formalin-fixed, paraffin-embedded tissue sections 
that were microdissected from representative re­
gions of the tumor (Fig. 2A). An example of the 
CGH analysis is presented for case 15 as a ratio
average ratio profile of 10 metaphases of the same 
case (Fig. 2D,E). Average ratio profiles were used 
for mapping of copy num ber changes in all in­
stances. Chromosomal aberrations were detected in 
all 30 cases; the average num ber of chromosomal 
aberrations per case was 8.2. D espite the high 
number of chromosomal aberrations, a recurrent 
and specific pattern emerged in advanced-stage 
cervical carcinomas: the most frequent copy num ­
ber alteration was a gain of chromosome arm 3q, 
which occurred in 23 of the 30 cases (77%). In 4 
cases, the gain of 3 q was present as a high level 
copy num ber increase (amplification). T h e  consen­
sus region of 3q amplification was mapped to 
chromosomal bands 3q26-27. Gain of genetic mate­
rial was also identified on chromosome arms lq
(14/30), 5p (9/30), 6p (8/30), and 2 0 p (7/30). Whole-
arm amplifications were frequently observed on 5p. 
Regional high level copy num ber increases (ampli­
fications) were mapped to chromosomal bands
3q26-27, 9p23-24, llq22-23, and 12pl3. T h e  most
common chromosomal copy num ber decrease was 
mapped to chromosome arm 3p (15/30), band 
2q36-37 (10/30), 6 q (8/30), 8p (7/30), 4p (7/30), and 
13q (8/30). A summary of chromosomal gains and 
losses is presented in Figure 3.
HPV Genotyping
T h e  presence of HPV genomes was analyzed by 
PCR in the same D N A  as for CGH. Ail samples
could be analyzed successfully with a primer for the 
p-globin gene used as a control. HPV genomes 
were not detected in 5 cases. Twenty-five tumor 
samples yielded positive test results. Invariably, the 
detected HPV belonged to the high-risk group. 
HPV 16 accounted for 48% of the infections, 
followed by HPV 45 (6/25). T h e  results are summa­
rized in Table 1.
DNA Ploidy Measurement
DNA ploidy was measured on consecutive tissue 
sections by image cytom etry Image cytometry 
complements the CGH analyses by providing infor­
mation of the DNA ploidy .that cannot be gained
(
from CGH experiments alone. N one of the tumors 
showed a normal diploid DNA content. Most cases 
had crude aneuploidy, with either proliferating 
tetraploid cell populations or highly aneuploid cell 
populations; more than 2 0 % of the cells exceeded 
5c values. T h e  results are presented in Table 1.
Immunocytochemistry
T h e  antibodies MIB-1, which is directed against
image of a representative metaphase cell and as an the Ki-67 antigen, D O -1, which reacts with T P 53 ,
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Figure 2. Iminunohistochemical detection of Ki-67 (A), TP53 (B), 
and p 2 l / WA F - l  (C) of  case IS. Immunoreactive nuclei appear dark 
brown. The tissue was counterstained w ith  H&E, which appears blue. In 
this case, the proliferative activity was increased in 80% of the cells (A), 
TP53 expression was negligibly low  (<2% ) (B), and p 2 l / WA F - l  
immunoreactivity was present in 60% of the cells (C). D: A ratio image 
of case I 5. Blue indicates a balance between tum or and test genomes, 
red reflects a loss of genetic material in the tum or D N A, and green
shows regions that are gained in the tumor, E: The average ratio profile 
that was computed on the basis o f IÛ ratio images. The three vertical 
lines on the right side of the chromosome ideograms reflect different 
values of the fluorescence ratio between tumor and normal DNA. The 
values are 0.75, I , and i .25 from (eft to right, respectively. Copy number 
changes are present on 1, 3q, 5p, 6p, 9p, and X (gains) and 3p, 6q, and I 3 
(losses).
Lind p2 l/W A F- l. which I') in cl s r<> rhc p.S^-activatcd 
eel! cyd c  regulator \VAl*'~h were used for immuno- 
histochemical staining of consecutive tissue sec­
tions. Proliferative activity was, in <j;eneral, mark-
4 < ’
edlv increased, with most tumor samples showing
strong reactivity in 70-90% of the cells. With the
« *
exception of two cases ( I I and 20), immunorcactiv-
itv with I )( )-1 (directed against T P 5 3) was negative
i  »
or only slightly increased. Imnninorcactivifv for
« J > . #
p2l/\\V\l;-l was generally elevated, d'he strong
238 HESELMEYEH ET AL
1
I
6
2 3
7 8
•?is¿M
I1
4 5
9
///
10
///
11
1
12
///
13
19
///
14
20
///
15
P31
21 22
16 17
X
Figure 3. Karyogram of gains and losses in 30 cases of advanced-stage cervical carcinoma. Lines on the 
right side of the ideograms reflect copy number increases; lines on the left represent copy number 
decreases. Heavy lines symbolize high level copy number increases (amplifications).
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Y
expression of TP53 in cases 11 (60% of the cells 
reacting) and 20 (80%) did not affect the expression 
pattern of WAF-1. Examples of the immunohisto-
chemical findings (case 15) are provided in Figure
2A-C. T h e  quantification of the data is summarized 
in Table 1.
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This study summarizes the results of a combined 
henotype/genotype analysis of 30 cases of acl- 
inced-stage cervical carcinomas. By using C G H  as
molecular cytogenetic screening test for copy 
umber changes, we identified a recurrent and 
age-specific pattern of chromosomal aberrations 
l these tumors. Proliferation analysis and measure- 
lent of the cellular D N A  content revealed that 
jvanced-stage cervical tumors were highly prolif- 
rative and aneuploid, frequently with stemlines in 
le tetraploid region. We examined the expression 
;atus of TP53 and p21/WAF-l to understand the
ivolvement of p53 in the progression of cervical 
ircinomas. High-risk. HPV types were detected in 
3% of the tumors.
C G H  analysis uncovered a recurrent pattern of 
iromosomal aberrations in advanced-stage dis- 
ase. Most commonly, we observed a gain of 
hiromosome arm 3q (23 of 30 tumors). In 4 cases, 
lese gains were present as high level copy number 
lcreases. T h e  smallest amplicon could be mapped 
) chromosomal bands 3q26-27. It is likely that this 
igion harbors a gene or genes whose gain of 
.inction is important in cervical carcinogenesis. 
)ther characteristic copy num ber increases were 
lapped to chromosome arm 5p, remarkably often 
s high level copy num ber increases, and to chromo- 
3me arm lq. T h e  involvement of chromosome arm 
q was suspected by G-banding analysis (Popescu 
nd DiPaolo, 1992). Atkin et al. (1990) have ob-
srved a marker chromosome in many cervical 
arcinomas and suggested that it reflects an isochro- 
losome 4p or 5p. T h e  frequent gain of 5p material 
i our collection of advanced cervical carcinomas 
uggests that this marker is likely to be derived 
:om an i(5)(pl0). It  is noteworthy in this context 
tvat Mitra and colleagues (1995) identified loss of 
eterozygosity (LO H ) on chromosome arm 5p in 
reinvasive lesions. However, the gain of 5p seems 
3 be a recurrent event during progression to 
dvanced-stage carcinomas. Consistent losses, in­
dicative of chromosomes where tumor suppressor 
;enes reside, were mapped to chromosome arms 
p, 8p, 13q, and 2q. T h e  loss of chromosome arm 3p
5 also a frequent finding in L O H  studies (Mullokan- 
lov et al., 1996). Chromosome arm 1 lq  showed 
opy num ber decreases in 6 cases. L O H  studies 
v i t h  markers for this chromosome arm indicated a 
ecurrent loss in cervical carcinomas (Srivatsan et
1., 1991). Twenty-two whole-arm or band-specific
amplifications were mapped. Compared to the 
number of amplifications in small cell lung carcino­
mas (Ried et al., 1994; Levin et a l ,  1995), aneuploid 
breast carcinomas (Kallioniemi et al., 1994; Ried et 
al., 1995), and glioblastomas (Schrock et al., 1994; 
Kim et al., 1995), this number is low. T h e  average 
number of chromosomal aberrations (ANCA) per 
case amounts to 8.2. This is similar to the ANCA 
index established by use of CGH analysis of glioblas­
tomas, where it is 8.3 (Schrock et al., 1994), and 
aneuploid breast carcinomas, where it is 6.8 (Ried 
et al., 1995), indicating a high genetic instability.
We have previously analyzed, by CGH, D N A  
copy num ber changes that occur in the progression 
from normal cervical epithelium to stage I invasive 
carcinomas (Heselmeyer e t  al, 1996). N ine of 10 of 
the invasive carcinomas exhibited a gain of chromo­
some arm 3q, whereas this aberration was present in 
only 1 of 13 severe dysplasias. It is, therefore, 
obvious that the gain of chromosome arm 3q occurs 
at the transition from preinvasive to invasive dis­
ease. T h e  analysis of 30 cases of advanced-stage 
carcinomas shows that this particular chromosomal 
aberration was maintained in the majority of the 
tumors (77%). However, additional chromosomal 
changes emerged that include gains of chromosome 
arms lq  and 5p, as well as losses of 2q. T h e  analyses 
allow us to identify a stage-specific pattern of 
chromosomal aberrations, in which 3q gain is an 
early event that coincides with the progression from 
preinvasive lesions to stage I invasive carcinomas. 
T h e  gains of chromosome arms lq  and 5p, however, 
occur in advanced stages of tumor progression.
T h e  immunohistochemical pattern in advanced 
cervical carcinomas can be summarized as follows: 
TP53 expression is relatively low, and only two 
cases revealed increased immunoreactivity. 
p21/WAF~l is generally elevated. This is in sharp 
contrast to colon carcinomas, where TP53 levels are 
dramatically increased and immunoreactivity for 
p21/WAF-l is low (Ried et al., 1996). We hypoth­
esized that the difference in immunophenotype is 
due to the frequent presence of high-risk HPV in 
advanced-stage cervical carcinomas. Interestingly, a 
strikingly similar immunophenotypic response was 
observed in a series of squamous cell carcinomas of 
the anal canal, which, like cervical carcinomas, are 
often associated with HPV infection. Apparently 
the presence of HPV is not sufficient to inactivate 
all p53 activity, because p21/WAF-l is still in­
creased (Heselmeyer et al., in press).
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'The correlation of phenotype/genotype in cervi­
cal carcinomas can be summarized as follows: HPV 
infection is present in mildly dysplastic lesions and 
persists throughout advanced stages. Virtually all
I IP Vs in lesions with increased levels of dysplasia
belong to the high-risk group. Proliferative activity 
reaches maximum levels in severely dysplastic 
lesions and remains elevated during the progression 
to advanced-stage tumors. T h e  tetraploidization 
that we observed already in mild dysplasia is 
replaced by cells with profound aneuploidy 
(Heselmeyer et al., 1996). T h e  gain of chromosome 
arm 3cj is an early event in cervical carcinogenesis 
and occurs at the transition from pre malign ant 
lesions to invasive carcinoma, stage I. During pro­
gression to advanced-stage disease, additional chro­
mosomal aberrations are acquired, namely, the gain 
of chromosome arms lq  and 5p, as well as the loss of 
chromosomal bands 2q36-37, T h e  gain of chromo­
some 3q, however, persists.
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